Background illustration for clinical trials search

Paid Clinical Trials Fayetteville

Discover 156 paid clinical trials in Fayetteville, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Compare the PK Characteristics, Safety, Tolerability, and Immunogenicity of HLX15-SC With DARZALEX FASPRO® in Combination With Lenalidomide and Dexamethasone (Rd) in Transplant-ineligible Patients With Newly Diagnosed Multiple Myeloma

for
Multiple Myeloma (MM)
Location: Springdale AR, Houston TX, Covington LA, Dyer IN,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT07477587

Phase 1, Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Springdale AR, Dallas TX, Omaha NE, Decatur IL,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07063745

Phase 2, Phase 3, Recruiting

First-in-Human Study of ADCE-B05 in Patients With Advanced Solid Tumors

for
Solid Tumors (Phase 1)
Location: Springdale AR, Houston TX, New Haven CT
Sponsor: Adcendo ApS

Sex: All

Age: 18+

Code: NCT07362888

Phase 1, Recruiting

Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or Lymphomas

for
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer,
Location: Springdale AR
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT05415098

Phase 1, Recruiting

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

for
Hematologic Malignancies, Waldenstroms Macroglobulinaemia,
Location: Springdale AR, Dallas TX, Denver CO, Toronto,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT04728893

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).

for
Leukemia, Lymphocytic, Chronic, B-Cell,
Location: Springdale AR, Kansas City MO, Hattiesburg MS,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT05947851

Phase 3, Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Springdale AR, St Louis MO, Fort Worth TX,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer

for
Advanced Breast Cancer
Location: Springdale AR, Fairway KS, Germantown TN, Dallas TX,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06638307

Phase 1, Recruiting

Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy

for
NSCLC Stage IV
Location: Springdale AR, Springfield MO, Hot Springs AR,
Sponsor: ImmunityBio, Inc.

Sex: All

Age: 18 - 70+

Code: NCT06745908

Phase 3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Springdale AR, Springfield MO, Westwood KS, Memphis TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting

Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

for
Advanced Non-Small Cell Lung Cancer,
Location: Springdale AR, Merriam KS, Wichita KS, Denison TX,
Sponsor: Mirati Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04613596

Phase 2, Phase 3, Recruiting

Family Model DSME in FBOs in the RMI

for
Diabetes Mellitus, Type 2
Location: Springdale AR
Sponsor: University of Arkansas

Sex: All

Age: 18+

Code: NCT05502016

Recruiting

A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

for
B-Cell ALL, B-Cell Acute Lymphoblastic Leukaemia,
Location: Springdale AR, Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 1 - 23

Code: NCT07422337

Recruiting

A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

for
Age-related Macular Degeneration (AMD), Geographic Atrophy (GA)
Location: Springdale AR, Tulsa OK, Edmond OK, Lenexa KS,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 50 - 70+

Code: NCT06541704

Phase 3, Recruiting

Delivering HOPE (Helping Women Optimize Prenatal Equity)

for
Gestational Weight Gain, Diet, Healthy,
Location: Springdale AR, Lavaca AR, Marshall AR, Corning AR,
Sponsor: University of Arkansas

Sex: Female

Age: 16 - 44

Code: NCT06814509

Recruiting

Randomized Withdrawal Study in Patients With Schizophrenia

for
Schizophrenia
Location: Rogers AR, Richardson TX, Saint Charles MO, St Louis MO,
Sponsor: Vanda Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT06961968

Phase 3, Recruiting

A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid Tumors

for
Solid Tumors
Location: Rogers AR, Houston TX, San Antonio TX, Grand Rapids MI,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT07123103

Phase 1, Recruiting
New

A Study to Evaluate BMS-986511 in Adults With Major Depressive Disorder

for
Major Depressive Disorder
Location: Rogers AR, Little Rock AR, Atlanta GA
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18 - 65

Code: NCT07772531

Phase 2, Recruiting

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

for
Non-small Cell Lung Cancer
Location: Springdale AR, Kansas City MO, Shreveport LA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06692738

Phase 3, Recruiting

Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder

for
Generalized Anxiety Disorder
Location: Rogers AR, Little Rock AR, Norman OK, Dallas TX,
Sponsor: Intra-Cellular Therapies, Inc.

Sex: All

Age: 18+

Code: NCT06701903

Phase 2, Recruiting